About EUSA Pharma

Developer of late-stage oncology, pain control and critical care products based in the United Kingdom. The company offers biopharmaceutical products focused on oncology and rare diseases, for the treatment of oral mucositis, a common and debilitating side-effect of radiotherapy and high dose chemotherapy.

2006
Founded
2017
Investment Year
Healthcare
Sector

Recent News

1875 Finance: Private Markets Expansion
by ALP Media Team | April 9, 2025
AI Applications: The Winners of the LLM Investment Spree
by ALP Media Team | October 7, 2024
Alpha Leonis Partners Holds First Close for Venture Fund I
by ALP Media Team | September 23, 2024
CIO Commentary - September 2024
by David Pinkerton | September 17, 2024